Gene · 3738
Papers2,009
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,009
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chlorpromazine directly inhibits Kv1.3 channels by facilitating the inactivation of channels. | Mol Brain | 2025 | 40340862 | PubTator, text mining | PubMed |
| Block of Kv1 potassium channels and NMR structure of recombinant conotoxin κ-SrXIA. | Toxicon | 2025 | 40324600 | PubTator, text mining | PubMed |
| Vascular Smooth Muscle Cell Migration and P70S6K: Key Players in Intimal Hyperplasia Development. | J Am Heart Assoc | 2025 | 40314369 | PubTator, text mining | PubMed |
| Diverse β-bungarotoxin isoforms manifest different affinities to voltage-gated potassium channels of Kv1.x subfamily. | Arch Biochem Biophys | 2025 | 40287033 | PubTator, text mining | PubMed |
| Inhibition of cGMP-Signalling Rescues Retinal Ganglion Cells From Axotomy-Induced Degeneration. | J Neurochem | 2025 | 40270249 | PubTator, text mining | PubMed |
| 19F NMR chemical shift encoded peptide screening targeting the potassium channel Kv1.3. | Chem Commun (Camb) | 2025 | 40162494 | PubTator, text mining | PubMed |
| Short Peptides from Asian Scorpions: Bioactive Molecules with Promising Therapeutic Potential. | Toxins (Basel) | 2025 | 40137887 | PubTator, text mining | PubMed |
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR). | Am J Respir Crit Care Med | 2025 | 40035659 | PubTator, text mining | PubMed |
| Identification of KCNJ5 gene an adverse prognosis associated novel onco-ionchannel in Indian pancreatic cancer cohort. | Discov Oncol | 2025 | 39998707 | PubTator, text mining | PubMed |
| The First K+-Channel Blocker Described from Tityus fasciolatus Venom: The Purification, Molecular Cloning, and Functional Characterization of α-KTx4.9 (Tf5). | Toxins (Basel) | 2025 | 39998113 | PubTator, text mining | PubMed |
| Large-Scale AI-Based Structure and Activity Prediction Analysis of ShK Domain Peptides from Sea Anemones in the South China Sea. | Mar Drugs | 2025 | 39997209 | PubTator, text mining | PubMed |
| A novel spider toxin as a selective antagonist of the Kv1 subfamily of voltage-gated potassium channels through gating modulation. | J Biol Chem | 2025 | 39993525 | PubTator, text mining | PubMed |
| Inhibition of Kv1.3 channel restrains macrophage M2 polarization and ameliorates renal fibrosis via regulating STAT6 phosphorylation. | Pharmacol Res | 2025 | 39870185 | PubTator, text mining | PubMed |
| Identification of novel Kv1.3 channel-interacting proteins using proximity labelling in T-cells. | bioRxiv | 2025 | 39868101 | PubTator, text mining | PubMed |
| Insight into a multifunctional potassium channel Kv1.3 and its novel implication in chronic kidney disease. | Life Sci | 2025 | 39730039 | PubTator, text mining | PubMed |
| ShK-modified UCMSCs Inhibit M1-Like Macrophage Polarization and Alleviate Osteoarthritis Progression via PI3K/Akt Axis. | Adv Sci (Weinh) | 2025 | 39721037 | PubTator, text mining | PubMed |
| Neonatal neutrophils exhibit reduced NLRP3 inflammasome activation. | J Leukoc Biol | 2025 | 39312228 | PubTator, text mining | PubMed |
| Correction: Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study. | J Hematol Oncol | 2024 | 39709429 | PubTator, text mining | PubMed |
| Inhibition of K+ Channels Affects the Target Cell Killing Potential of CAR T Cells. | Cancers (Basel) | 2024 | 39594705 | PubTator, text mining | PubMed |
| Animal Venoms and Their Components: Molecular Mechanisms of Action V 2.0. | Toxins (Basel) | 2024 | 39591216 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3738/papers?page=5